Clinical trial
Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without…
NCT00458718 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00458718 |
|---|---|
| Title | Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch |
| Official title | Single Country, Double-Blind, Randomized, 2-Arm, Parallel-Group Study, Evaluating Efficacy and Safety of Rimonabant 20 mg OD, With/Without Association of Nicotine Patch, as Aid to Smoking Cessation During 9-Week Period |
| Acronym | CIRRUS |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | rimonabant (SR141716) |
| Enrollment | 755 |
| Start date | Sep 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Apr 11, 2007 |
| Last update posted | Apr 20, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: